Innovative Automation Strateos specializes in remote access laboratories and lab automation software that streamline experimental design and analysis, presenting opportunities to offer customized automation solutions that enhance research efficiency for life science organizations.

Strategic Partnerships Recent collaborations with industry giants like Eli Lilly and the launch of specialized labs such as Lilly Life Sciences Studio provide avenues to tailor advanced robotic laboratory services to large pharma companies seeking cutting-edge drug discovery support.

Funding & Growth With significant investment backed by Lux Capital and others, Strateos is expanding its technological capabilities, indicating potential for upselling innovative software and hardware solutions to biotech firms interested in high-throughput automation and data-driven discovery.

Research & Development Active development of in-silico screening models and ‘idea-to-data’ solutions demonstrate a focus on integrating computational biology and automation, creating opportunities to promote integrated software platforms for computational and laboratory integration.

Market Positioning Operating in the niche of remote labs within a competitive landscape with companies like Benchling and TetraScience, Strateos offers unique automation-as-a-service that can be positioned as a comprehensive platform for scalable scientific discovery, appealing to organizations aiming to modernize research workflows.